| Seq |
Description |
Document |
Type |
Size |
| 1 |
REGISTRATION STATEMENT |
fs12019_tffpharmaceuticals.htm |
S-1 |
3981243 |
| 2 |
SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT |
fs12019ex3-1_tffpharm.htm |
EX-3.1 |
97961 |
| 3 |
BYLAWS OF THE REGISTRANT |
fs12019ex3-2_tffpharm.htm |
EX-3.2 |
126123 |
| 4 |
AMENDED AND RESTATED BYLAWS OF THE REGISTRANT EFFECTIVE IMMEDIATELY FOLLOWING TH |
fs12019ex3-3_tffpharm.htm |
EX-3.3 |
184126 |
| 5 |
WARRANT DATED JANUARY 24, 2018 ISSUED TO LIQUID PATENT ADVISORS, LLC |
fs12019ex4-2_tffpharm.htm |
EX-4.2 |
76560 |
| 6 |
WARRANT DATED MARCH 13, 2018 ISSUED TO NATIONAL SECURITIES CORPORATION |
fs12019ex4-3_tffpharm.htm |
EX-4.3 |
70132 |
| 7 |
WARRANT DATED MARCH 22, 2018 ISSUED TO NATIONAL SECURITIES CORPORATION |
fs12019ex4-4_tffpharm.htm |
EX-4.4 |
69826 |
| 8 |
WARRANT DATED MAY 16, 2019 ISSUED TO NATIONAL SECURITIES CORPORATION |
fs12019ex4-5_tffpharm.htm |
EX-4.5 |
91687 |
| 9 |
WARRANT DATED MAY 23, 2019 ISSUED TO NATIONAL SECURITIES CORPORATION |
fs12019ex4-6_tffpharm.htm |
EX-4.6 |
67796 |
| 10 |
ENGAGEMENT AGREEMENT DATED JANUARY 26, 2018 BETWEEN LIQUID PATENT ADVISORS, LLC |
fs12019ex10-1_tffpharm.htm |
EX-10.1 |
56696 |
| 11 |
SECURITIES PURCHASE AGREEMENT DATED MARCH 13, 2018 BY AND AMONG THE REGISTRANT A |
fs12019ex10-2_tffpharm.htm |
EX-10.2 |
582253 |
| 12 |
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT DATED MAY 16, 2019 BY AND AMO |
fs12019ex10-3_tffpharm.htm |
EX-10.3 |
163191 |
| 13 |
CONTRIBUTION AND SUBSCRIPTION AGREEMENT DATED JANUARY 24, 2018 BETWEEN THE REGIS |
fs12019ex10-4_tffpharm.htm |
EX-10.4 |
29371 |
| 14 |
PATENT LICENSE AGREEMENT DATED JULY 8, 2015 BETWEEN LUNG THERAPEUTICS, INC. AND |
fs12019ex10-5_tffpharm.htm |
EX-10.5 |
277596 |
| 15 |
TFF PHARMACEUTICALS, INC. 2018 STOCK INCENTIVE PLAN |
fs12019ex10-6_tffpharm.htm |
EX-10.6 |
98154 |
| 16 |
AMENDED AND RESTATED CONSULTING AGREEMENT DATED DECEMBER 20, 2018 BETWEEN ROBERT |
fs12019ex10-7_tffpharm.htm |
EX-10.7 |
43299 |
| 17 |
CONSULTING AGREEMENT DATED FEBRUARY 12, 2018 BETWEEN DR. BRIAN WINDSOR AND THE R |
fs12019ex10-8_tffpharm.htm |
EX-10.8 |
57048 |
| 18 |
CONSULTING AGREEMENT DATED APRIL 23, 2018 BETWEEN GLENN MATTES AND THE REGISTRAN |
fs12019ex10-9_tffpharm.htm |
EX-10.9 |
64893 |
| 19 |
LEASE AGREEMENT DATED OCTOBER 19, 2018 |
fs12019ex10-10_tffpharm.htm |
EX-10.10 |
306331 |
| 20 |
EXECUTIVE EMPLOYMENT AGREEMENT DATED DECEMBER 20, 2018 BETWEEN GLENN MATTES AND |
fs12019ex10-11_tffpharm.htm |
EX-10.11 |
49417 |
| 21 |
SECURITIES PURCHASE AGREEMENT DATED MAY 16, 2019 BY AND AMONG THE REGISTRANT AND |
fs12019ex10-12_tffpharm.htm |
EX-10.12 |
227050 |
| 22 |
AMENDMENT NO.1 TO PATENT LICENSE AGREEMENT DATED NOVEMBER 30, 2018 BETWEEN THE R |
fs12019ex10-13_tffpharm.htm |
EX-10.13 |
250191 |
| 23 |
EMPLOYMENT AGREEMENT, DATED FEBRUARY 15, 2019, BY AND BETWEEN THE REGISTRANT AND |
fs12019ex10-14_tffpharm.htm |
EX-10.14 |
57331 |
| 24 |
LIST OF SUBSIDIARIES |
fs12019ex21-1_tffpharm.htm |
EX-21.1 |
566 |
| 25 |
CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM |
fs12019ex23-1_tffpharm.htm |
EX-23.1 |
3346 |
| 26 |
GRAPHIC |
image.jpg |
GRAPHIC |
465375 |
| |
Complete submission text file |
0001213900-19-016393.txt |
|
7672924 |
